Truveta data shows 182,101 patients started the Wegovy pill in nine months
About 41% had no sign of earlier GLP-1 use, while 26% switched from injectable semaglutide or tirzepatide. Most prescribers were general practice providers.
Recap by typeshit. Full story at Truveta.